121 related articles for article (PubMed ID: 31092769)
1. Immune Disorder in Atherosclerotic Cardiovascular Disease - Clinical Implications of Using Circulating T-Cell Subsets as Biomarkers.
Neupane R; Jin X; Sasaki T; Li X; Murohara T; Cheng XW
Circ J; 2019 Jun; 83(7):1431-1438. PubMed ID: 31092769
[TBL] [Abstract][Full Text] [Related]
2. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
Wan Q; Liu Z; Yang M; Wu J
Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
[TBL] [Abstract][Full Text] [Related]
3. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
4. Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.
Jacobo P; Guazzone VA; Jarazo-Dietrich S; Theas MS; Lustig L
J Reprod Immunol; 2009 Jul; 81(1):44-54. PubMed ID: 19520436
[TBL] [Abstract][Full Text] [Related]
5. The Significance of Tumor Necrosis Factor Receptor Type II in CD8
Ye LL; Wei XS; Zhang M; Niu YR; Zhou Q
Front Immunol; 2018; 9():583. PubMed ID: 29623079
[TBL] [Abstract][Full Text] [Related]
6. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
7. [Lymphocyte activation markers in patients with ovarian cancer].
Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
[TBL] [Abstract][Full Text] [Related]
8. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
9. Influence of CD4+/CD25+ regulatory T cells on atherogenesis in patients with end-stage kidney disease.
Meier P; Meier R; Blanc E
Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):987-97. PubMed ID: 18666849
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ regulatory T cells control innate immune reactivity after injury.
Murphy TJ; Ni Choileain N; Zang Y; Mannick JA; Lederer JA
J Immunol; 2005 Mar; 174(5):2957-63. PubMed ID: 15728508
[TBL] [Abstract][Full Text] [Related]
11. A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis.
van Dijk RA; Duinisveld AJ; Schaapherder AF; Mulder-Stapel A; Hamming JF; Kuiper J; de Boer OJ; van der Wal AC; Kolodgie FD; Virmani R; Lindeman JH
J Am Heart Assoc; 2015 Mar; 4(4):. PubMed ID: 25814626
[TBL] [Abstract][Full Text] [Related]
12. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.
Kaur G; Goodall JC; Jarvis LB; Hill Gaston JS
Mol Immunol; 2010; 48(1-3):321-32. PubMed ID: 20688398
[TBL] [Abstract][Full Text] [Related]
14. Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease.
Tsilingiri K; de la Fuente H; Relaño M; Sánchez-Díaz R; Rodríguez C; Crespo J; Sánchez-Cabo F; Dopazo A; Alonso-Lebrero JL; Vara A; Vázquez J; Casasnovas JM; Alfonso F; Ibáñez B; Fuster V; Martínez-González J; Martín P; Sánchez-Madrid F
Circulation; 2019 Jan; 139(2):243-255. PubMed ID: 30586697
[TBL] [Abstract][Full Text] [Related]
15. CD4+ CD25+ Treg regulate the contribution of CD8+ T-cell subsets in repopulation of the lymphopenic environment.
Almeida AR; Ciernik IF; Sallusto F; Lanzavecchia A
Eur J Immunol; 2010 Dec; 40(12):3478-88. PubMed ID: 21108468
[TBL] [Abstract][Full Text] [Related]
16. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
[TBL] [Abstract][Full Text] [Related]
17. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review.
Bao Y; Cao X
J Autoimmun; 2014 Dec; 55():10-23. PubMed ID: 24794622
[TBL] [Abstract][Full Text] [Related]
18. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
19. The many faces of CD8+ T cells in atherosclerosis.
van Duijn J; Kuiper J; Slütter B
Curr Opin Lipidol; 2018 Oct; 29(5):411-416. PubMed ID: 30020198
[TBL] [Abstract][Full Text] [Related]
20. Low Blood Content of IL-10-Producing CD4
Filatova AY; Pylaeva EA; Potekhina AV; Ruleva NY; Klesareva EA; Radyukhina NV; Masenko VP; Shchinova AM; Noeva EA; Provatorov SI; Afanas'eva OI; Aref'eva TI
Bull Exp Biol Med; 2019 Jan; 166(3):330-333. PubMed ID: 30627915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
